Crown prosecutors dropped the COVID-related public health charges against pizzeria owner Jesse Johnson after a two-year court battle. Johnson's business went bankrupt due to provincial health orders, causing job losses for 30 employees and two families. A new report led by Preston Manning highlights the failure of governments and courts to protect people's rights during the pandemic.
There is a much-respected maxim in legal circles that says justice delayed is justice denied. Such sayings are of little use to people like pizzeria owner Jesse Johnson, whose two-year court battle came to an end this week when Crown prosecutors dropped his COVID-related public health charges. Johnson, the owner of a successful Calgary restaurant of two decades, Without Papers Pizza, was alleged to have not checked for vaccine passports during the pandemic.
His business went bankrupt due to provincial health orders, causing two families to lose their livelihoods and 30 employees to lose their jobs. A new report from a panel led by veteran politician Preston Manning, which looks to strengthen individual and business rights during future emergencies like the COVID pandemic, will also be of little use to Johnson — but it may help other businesses facing similar catastrophic conditions. In particular, the 116-page document lamented the failure of governments and courts to protect people’s rights during the pandemic. Vaccine mandates limited freedom of conscience, said the report
Pizzeria Owner COVID Charges Court Battle Vaccine Passports Bankruptcy Job Losses Report Government Failure Rights Protection
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Johnson & Johnson lifts profit outlook on strong demand for anti-inflammatory drug StelaraJohnson & Johnson’s third-quarter total sales of $21.35-billion came in above analysts’ estimates of $21.04-billion
Read more »
Johnson & Johnson raises guidance, Q3 results top estimatesJohnson & Johnson (JNJ) reported third quarter results that topped analyst estimates on both the top and bottom lines. The health care company also raised...
Read more »
J&J and AstraZeneca Vie to Dominate New Era in Lung-Cancer CareA rivalry is heating up between AstraZeneca Plc and Johnson & Johnson in lung cancer.
Read more »